You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 142 No. 3, March 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (66)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Phosphate Therapy in Diabetic Ketoacidosis

Howard K. Wilson, MD; Steven P. Keuer, MD; A. Scott Lea, MD; Aubrey E. Boyd III, MD; Garabed Eknoyan, MD

Arch Intern Med. 1982;142(3):517-520.


Abstract



To determine the efficacy of phosphate replacement in the therapy for diabetic ketoacidosis (DKA), 44 patients were randomly assigned to three treatment groups: those who received no phosphate replacement, those who received 15 mmole of sodium phosphate at the fourth hour, or those who received 15 mmole of sodium phosphate at 2, 6, and 10 hours. All patients were treated with intravenous insulin injection (0.1 units/kg/hr), fluids, and potassium. Four hours after a 15-mmole sodium phosphate infusion, the serum phosphate level was 2.8 ± 0.8 mg/dl vs 2.1 ± 0.8 mg/dL in the control patients; however, this dose was insufficient to maintain the serum phosphate level at 16 and 24 hours. Forty-five millimoles of phosphate prevented severe hypophosphatemia in all but one patient and produced substantially higher phosphate levels at 8, 16, and 24 hours. Phosphate therapy did not affect the duration of DKA, dose of insulin required to correct the acidosis, abnormal muscle enzyme levels, glucose disappearance, or morbidity and mortality. Although theoretically appealing, phosphate therapy is not an essential part of the therapy for DKA in most patients.

(Arch Intern Med 1982;142:517-520)



Author Affiliations



From the Department of Medicine, Baylor College of Medicine, Houston.


Footnotes



Accepted for publication June 7, 1981.

Reprint requests to 6560 Fannin, Suite 815, Houston, TX 77030 (Dr Wilson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Weight loss and nausea in a patient taking digoxin
Kong et al.
BMJ 2011;343:d4617-d4617.
FULL TEXT  

13.4.10.1 Hyperglycaemic crises in adult patients with diabetes mellitus
Kitabchi and Nyenwe
Oxford Textbook of Endocrinology and Diabetes 2011;2:med-9780199235292-chapter-med-9780199235292-chapter.
ABSTRACT | FULL TEXT  

Diabetic and endocrine emergencies
Kearney and Dang
Postgrad. Med. J. 2007;83:79-86.
ABSTRACT | FULL TEXT  

Diabetic Ketoacidosis in Infants, Children, and Adolescents: A consensus statement from the American Diabetes Association
Wolfsdorf et al.
Diabetes Care 2006;29:1150-1159.
FULL TEXT  

Hyperglycaemic crises and lactic acidosis in diabetes mellitus
English and Williams
Postgrad. Med. J. 2004;80:253-261.
ABSTRACT | FULL TEXT  

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents
Dunger et al.
Arch. Dis. Child. 2004;89:188-194.
ABSTRACT | FULL TEXT  

European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents
Dunger et al.
Pediatrics 2004;113:e133-e140.
FULL TEXT  

Emergency management of diabetic ketoacidosis in adults
Hardern and Quinn
Emerg. Med. J. 2003;20:210-213.
ABSTRACT | FULL TEXT  

Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi et al.
Diabetes Care 2001;24:131-153.
FULL TEXT  

Observations of Hypophosphatemia and Its Management in Nutrition Support
Sacks et al.
Nutr Clin Pract 1994;9:105-108.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.